載入...
Improved Therapy by Pretargeted Radioimmunotherapy of Non-Hodgkin Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody
We examined whether a pretargeting method using a new, recombinant anti-CD20 bispecific antibody (bsMAb) followed by (90)Y-DOTA-peptide could reduce hematological toxicity yet improve therapeutic responses, compared to conventional (90)Y-anti-CD20 IgG and a chemically-conjugated bsMAb. TF4, a humani...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2008
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2585743/ https://ncbi.nlm.nih.gov/pubmed/18593929 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-08-0037 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|